Bibliographic Details
| Title: |
436TiP - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study. |
| Authors: |
Brahm, C.G.1 (AUTHOR), van Linde, M.E.1 (AUTHOR), Labots, M.1 (AUTHOR), Kouwenhoven, M.C.M.2 (AUTHOR), Sanchez Aliaga, E.3 (AUTHOR), Enting, R.H.4 (AUTHOR), Appelman, A.P.A.5 (AUTHOR), Nuver, J.6 (AUTHOR), Walenkamp, A.M.E.6 (AUTHOR), Verheul, H.M.W.7 (AUTHOR) |
| Source: |
Annals of Oncology. 2019 Supplement 6, Vol. 30, pv157-v158. 2p. |
| Database: |
Academic Search Ultimate |
